Small Virus, Big Disruption: The NB.1.8.1 COVID Variant Is Heading for America – Are You Ready to Unite Against the Pandemic?

Harmonic Healing
36 followers
44 Video Views·May 30, 2025
The novel coronavirus is still mutating, posing a challenge to global public health. Recently, the NB.1.8.1 variant, a descendant of the Omicron JN.1 lineage, has spread rapidly in many parts of the world, attracting widespread attention 1. This film will deeply analyze the characteristics of NB.1.8.1, explore comprehensive response plans such as Western medicine, traditional Chinese medicine and diet therapy, and try to use the theory of the Five Elements and Six Qi of traditional Chinese medicine to look forward to the possible trend of future variants and the response wisdom of traditional Chinese medicine.
Welcome to Harmonic Healing Channel.
In the face of the ever-evolving COVID-19 pandemic, the emergence of the NB1.8.1
variant presents both challenges and opportunities for global public health.
This variant, a descendant of the Omicron JN.1 lineage, has exhibited remarkable propagation
across multiple global regions, demanding immediate attention.
To comprehend the significance of the NB.1.8.1 variant,
we delve into its origin, characteristics,
and the multifaceted strategies for comprehensive response.
Our approach integrates conventional Western medicine,
the holistic principles of traditional Chinese medicine,
and evidence-based nutritional interventions.
Additionally, we leverage the wisdom of the TCM theory of the five movements and six qi
to anticipate potential future trends in viral mutations.
By understanding the unique characteristics of the NB.1.8.1 variant
and applying the principles of TCM,
we aim to provide valuable insights for healthcare professionals and the general public.
This knowledge empowers us to develop effective prevention and treatment strategies
while offering a glimpse into the future of this pandemic.
Emerging in January 2025, the NB.1.8.1 variant traces its lineage back to the recombinant
variant XDV1.5.1, a member of the Omicron JN.1 family.
After establishing itself as the dominant strain in China,
it rapidly spread across Asia, affecting countries like Singapore, Hong Kong, and India.
Subsequently, international travel facilitated its transmission to European and American nations,
including the United States, France, and Germany.
By May 2025, the World Health Organization designated NB.1.8.1 as a variant under monitoring.
Notably, by the end of May, 22 countries had reported NB.1.8.1 sequences,
signifying its global reach and transmissibility.
The surge in infections in China since April 2025 has been marked by a notable
increase in COVID-19 positivity rates, according to data from the China CDC.
By April 2025, the positivity rate for SARS-CoV-2 among influenza-like illness,
outpatient, and emergency cases rose from 7.5% to 16.2%.
Among hospitalized severe acute respiratory infection cases,
the positivity rate increased from 3.3% to 6.3%.
Official Chinese sources also identify NB.1.8.1, a sixth-generation subbranch of the XDV variant,
as the primary circulating strain.
The enhanced transmissibility of NB.1.8.1 is attributed to its unique genetic composition.
The spike protein of the virus has undergone several significant mutations,
including a 435S, V445H, and K478I.
These mutations may augment the virus's capacity to bind to human ACE2 receptors,
thereby facilitating cellular entry and increasing transmissibility.
For instance, the K478I mutation may enhance the virus's ability to evade certain neutralizing
antibodies, while the A435S mutation may diminish the efficacy of various monoclonal antibodies.
The virus appears to be continually refining its mechanisms for host cell invasion.
Experts, including Zhang Nanshan and those from Peking Union Medical College Hospital,
have observed that the JN11 strain exhibits a heightened affinity for the upper respiratory
tract, such as the nosopharynx and throat, leading to symptoms such as dry cough and
sore throat, rather than high fever.
This is attributed to the virus's decreased propensity to affect the lungs and cause
severe pneumonia compared to earlier variants.
The recent JN1 subvariant waves, including that of NB.1.8.1 infection,
have demonstrated some shifts in symptoms, while general symptoms such as sore throat,
fatigue, mild cough, fever, muscle aches, and nasal congestion are still prevalent.
Fever is becoming less common.
This may be due to pre-existing immunity from vaccination or prior infection, which
could lead the body to mount a more subtle immune response.
Reports from Taiwan and China indicate that NB.1.8.1 infection may be associated with
a higher incidence of severe pharyngitis.
Some patients may experience persistent low-grade temperature irregularities or
gastrointestinal symptoms such as headache, nausea, and loss of appetite.
Clinicians have noted that over 40% of individuals diagnosed in the current wave
may not present with fever.
Sick signals are emerging as potential indicators of new variant infections in the absence of
fever.
They are itchy or dry throat, dysphagia, persistent dry cough exacerbated by swallowing
rhinitis and sneezing, generalized myalgia, dorsalgia, and lumbar pain, and persistent
fatigue, non-restorative sleep.
These symptoms should not be casually dismissed as common cold or allergy symptoms.
On the ground reports from China, reports from Guangzhou and Shanghai suggest a discrepancy
between official narratives of a slowing trend and the experiences of citizens and medical
professionals.
Some citizens report widespread familial infections with severe symptoms.
A clinic doctor in Guangzhou stated that many adults and children were infected and the
symptoms were generally more severe than the common cold.
This doctor also reported the death of a physician at a grade A class 3 hospital due to COVID-19,
causing concern among medical personnel.
According to this doctor, over half of the patients visiting his clinic exhibited symptoms
suggestive of COVID-19, but testing was often not performed.
He raised concerns regarding alleged underreporting and potential avoidance of testing to prevent
public anxiety.
Severe cases requiring hospitalization and ICU admission were reported.
Allegations were made regarding instructions not to report confirmed cases and to focus
on disinfection measures.
Official assessments indicate that the severity of illness caused by NB.1.8.1 has not increased
significantly compared to other prevalent Omicron variants.
The WHO's preliminary assessment indicates a low additional global public health risk.
Existing diagnostic tests remain effective for detecting JN1 and its descendant variants.
However, it is important to acknowledge the limitations of these reports and the potential
biases or challenges faced by healthcare workers and researchers in providing an accurate account
of the situation.
Access to reliable information might be restricted, and the true extent of the impact of NB.1.8.1
may not be fully known.
Continued monitoring and transparency are crucial for a comprehensive understanding
of the variants, characteristics, and implications.
Understanding Long COVID
A significant number of individuals experience persistent symptoms, termed long COVID, following
the acute phase of infection.
Common long COVID symptoms include cognitive impairment, anxiety, palpitations, chest
tightness, and persistent fatigue.
Research indicates that up to 30 percent of patients may experience long COVID symptoms
three months post-infection.
The risk is higher for individuals aged 65 and older.
Elderly individuals have a 1.8 times higher risk of developing symptoms such as cognitive
decline, fatigue, and palpitations.
This increased vulnerability is attributed to slower immune function and recovery, comorbidities,
and weakened organ function.
Vaccination remains a crucial defense mechanism.
Updated vaccines targeting JN1 are anticipated to confer cross-protection against NB.1.8.1.
Existing or Updated JN1 Vaccines remain effective against symptomatic
infection and severe disease caused by NB.1.8.1.
For infected individuals, timely antiviral treatment is essential.
Medications such as Paxlavid are generally effective if administered within five days
of symptom onset.
Other drugs, such as remdesivir and molnupiravir, also require early initiation.
Continuous monitoring of drug susceptibility is vital.
The emergence of the NB.1.8.1 variant underscores the importance of a comprehensive and multi-pronged
approach to pandemic preparedness and response.
Strengthening epidemiological surveillance is crucial for early detection and tracking
of viral mutations, informing effective public health interventions.
Continued investment in vaccine and pharmaceutical development holds immense potential for mitigating
the impact of this variant.
Moreover, fostering research into integrative medicine, such as t-can provide alternative
therapeutic options and insights into holistic healing.
Validating and integrating traditional medicine practices alongside conventional western medicine
can offer a more complete and patient-centered approach to healthcare.
Equally important is the need for open communication and collaboration among nations, healthcare
professionals and researchers worldwide.
Sharing data, best practices and resources is essential for developing globally effective
strategies to combat the challenges posed by NB.1.8.1 and future variants.
From a traditional Chinese medicine perspective, COVID-19 is classified as an epidemic, disease
arising from external pathogenic factors, and deficiency of vital energy.
TCM characterizes Omicron and its variants as manifesting a combination of wind, heat,
dampness, and toxin.
Pattern differentiation and treatment are central to TCM's approach.
Common TCM pattern differentiations include wind heat invading the lungs, cold dampness
stagnating in the lungs, damp toxins stagnating in the lungs, and qi and yin deficiency.
China's official guidelines provide detailed guidance on pattern differentiation and treatments.
External TCM therapies such as acupuncture, cupping, gua sha, moxibustion and herbal medicine
are widely applied.
A balanced diet rich in vitamins, minerals and antioxidants plays a pivotal role in supporting
the immune system and overall health.
TCM dietary therapy focuses on individualized recommendations based on pattern differentiation
and the six tastes.
Lifestyle modifications including regular exercise, stress management and adequate sleep
are emphasized.
Personal protective measures such as wearing masks, frequent hand washing and avoiding
close contact with infected individuals are crucial.
Environmental hygiene measures including regular disinfection of surfaces and proper ventilation
are also recommended.
Recovery strategies.
Learning from experience.
TCM encourages a gradual and balanced approach to recovery.
Key strategies include appropriate diet, pacing and gradual return to activity, personalized
treatment plans and ongoing health monitoring.
The theory of wu yan lu qi predicts climatic patterns and corresponding disease trends.
This theory anticipates prevalent wind and fire factors in 2025.
Future variants of COVID-19 may exhibit a more pronounced wind and fire nature.
TCM strategies should prioritize protecting the lung metal, tonifying qi and nourishing
yin.
If you find this helpful, please subscribe, hit the like button, and share this to anyone
who might benefit.
